Literature DB >> 12398957

In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction.

Miwako Shihara1, Hiroyuki Tsutsui, Miyuki Tsuchihashi, Hideo Tada, Suminori Kono, Akira Takeshita.   

Abstract

Previous studies have identified risk factors for short- and long-term outcomes for patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). However, it remains unknown whether they can be generalized to current PCI practice for a broader cohort of patients. We analyzed the follow-up information (mortality and revascularization procedures) obtained from a nationwide Japanese registry during 1997 of a total of 2,211 patients with AMI who underwent PCI at 143 facilities. Demographic, clinical, angiographic, and procedural variables were submitted to statistical analysis to detect the risk factors of adverse outcomes. In-hospital and 1-year mortality rates were 7.1% and 10.9%, respectively. The most important risk factor for in-hospital death was attempted PCI of the left main (LM) coronary artery. Further independent risk factors for death were left ventricular (LV) dysfunction (ejection fraction </=40%), LM disease, older age, multivessel disease, cerebrovascular disease, and diabetes. The receiver-operating characteristics curve for the predicted probability of death was 0.88, indicating a good ability to discriminate high-risk patients. Independent risk factors for 1-year postdischarge mortality were LV dysfunction, older age, renal failure, multivessel disease, and diabetes. The incidence of the need for repeat PCI or bypass surgery was significantly higher in patients with multivessel and LM disease. PCI is a valuable treatment strategy for a broad spectrum of patients with AMI. However, the mortality for patients with LM disease and poor LV function is still high even using current practice standards.

Entities:  

Mesh:

Year:  2002        PMID: 12398957     DOI: 10.1016/s0002-9149(02)02656-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Long-term prognosis of patients with acute myocardial infarction due to unprotected left main coronary artery disease: a single-centre experience over 14 years.

Authors:  Li Xu; Hao Sun; Le-Feng Wang; Xin-Chun Yang; Kui-Bao Li; Da-Peng Zhang; Hong-Shi Wang; Wei-Ming Li
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

2.  Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience.

Authors:  G Parodi; G Memisha; R Valenti; M Trapani; A Migliorini; G M Santoro; D Antoniucci
Journal:  Heart       Date:  2005-04-06       Impact factor: 5.994

3.  Differences in the Selvester QRS score after primary PCI strategy and conservative treatment for STEMI patients with negative T waves.

Authors:  Egle Kalinauskiene; Dalia Gerviene; Ljuba Bacharova; Zora Krivosikova; Albinas Naudziunas
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-08-01       Impact factor: 1.468

4.  Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy.

Authors:  R J van der Schaaf; J R Timmer; J P Ottervanger; J C A Hoorntje; M-J de Boer; H Suryapranata; F Zijlstra; J-H E Dambrink
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

5.  Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Songsak Kiatchoosakun; Chaiyasith Wongwipaporn; Burabha Pussadhamma
Journal:  Heart Asia       Date:  2016-06-14

6.  A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.

Authors:  Ik-Kyung Jang; Veronica Pettigrew; Michael H Picard; Peter R Kowey; Valentin Demmel; Michael R Zile; Jun Tatsuno; Frans J Th Wackers; Mark Hibberd
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

7.  The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.

Authors:  Teodora Vichova; Jiri Knot; Jaroslav Ulman; Marek Maly; Zuzana Motovska
Journal:  Int Urol Nephrol       Date:  2016-03-19       Impact factor: 2.370

8.  Emergency coronary stenting of unprotected critical left main coronary artery stenosis in acute myocardial infarction and cardiogenic shock.

Authors:  H McArdle; M Bhandari; J Kovac
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

9.  Impact of multivessel coronary disease with chronic total occlusion on one-year mortality in patients with acute myocardial infarction.

Authors:  Ju Hwan Lee; Hun Sik Park; Hyeon Min Ryu; Hyunsang Lee; Myung Hwan Bae; Jang Hoon Lee; Dong Heon Yang; Yongkeun Cho; Shung Chull Chae; Jae-Eun Jun
Journal:  Korean Circ J       Date:  2012-02-27       Impact factor: 3.243

10.  Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients.

Authors:  Jia-Yin Sun; Lin Zhai; Qiao-Ling Li; Jia-Xin Ye; Li-Na Kang; Jun Xie; Biao Xu
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.